Fingerprint
Dive into the research topics of 'Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically